for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Astrazeneca Says Imfinzi New Dosing Approved In The US

Nov 20 (Reuters) - AstraZeneca PLC:

* ASTRAZENECA PLC - IMFINZI NEW DOSING APPROVED IN THE US

* ASTRAZENECA - FOUR-WEEK DOSING NOW APPROVED IN ALL IMFINZI INDICATIONS, REDUCING MEDICAL VISITS AND IMPROVING PATIENT CONVENIENCE

* ASTRAZENECA - FOUR-WEEK DOSING NOW APPROVED IN ALL IMFINZI INDICATIONS, REDUCING MEDICAL VISITS AND IMPROVING PATIENT CONVENIENCE Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up